Pregnancy termination at a viable stage in daily clinical practice: A nationwide mortality follow-back study in Flanders, Belgium.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
06 2023
Historique:
revised: 11 04 2023
received: 27 01 2023
accepted: 14 04 2023
medline: 12 6 2023
pubmed: 20 4 2023
entrez: 20 04 2023
Statut: ppublish

Résumé

Congenital malformations are frequently diagnosed prenatally even at a viable stage. No adequate registration of incidence and characteristics of late termination of pregnancy (TOP) or abortion for medical reasons exists in Flanders. Nationwide mortality follow-back survey sent to physicians signing death certificates of all stillbirths for 22 weeks gestation onward (September 2016-December 2017) in Flanders, Belgium. Questions measured whether late TOP preceded stillbirth, and which clinical and sociodemographic characteristics were indicated. Questionnaire data were linked with sociodemographic information from death certificates. Response rate was 56% (203/366). 38% of stillbirths (77/203) concerned late TOP. In 88.3% of late TOPs, physicians classified congenital anomalies of the foetus as serious or very serious (incompatibility with life outside the womb or severe neurological or physical impairment). In 26% of cases, late TOP was first suggested by the physician rather than spontaneously requested by parents (73%). 88% of late TOPs were discussed in open team meetings. 2/5 stillbirths were preceded by late TOP, indicating severe underreportation by existing registrations and a dire need for adequate registration methods. Although late TOP was most often explicitly requested by parents, in ¼ cases termination was suggested first by physicians. Parents are sometimes hesitant to bring up late TOP themselves, indicating that TOP should always be counselled as an equivalent option.

Identifiants

pubmed: 37076971
doi: 10.1002/pd.6356
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

781-791

Subventions

Organisme : Bijzonder Onderzoeksfonds UGent
ID : 01J06915
Organisme : Fonds Wetenschappelijk Onderzoek
ID : G041716N

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Bijma H, van der Heide A, Wildschut H. Decision-making after ultrasound diagnosis of fetal abnormality. Reprod Health Matters. 2008;16(31 Suppl):82-89. https://doi.org/10.1016/s0968-8080(08)31372-x
Gaille M. On prenatal diagnosis and the decision to continue or terminate a pregnancy in France: a clinical ethics study of unknown moral territories. Med Health Care Philos. 2016;19(3):381-391. https://doi.org/10.1007/s11019-016-9689-2
Gynecologistst RCoOa. Termination of Pregnancy for Fetal Abnormality in England, Scotland and Wales. RCOG; 2010.
Royal College of Obstetricians & Gynaecologists. Best Practice in Abortion Care; 2022.
Geneva: World Health Organization. Abortion Care Guideline; 2022.
Grether P, Lisker R, Loria A, Alvarez-del-Rio A. End-of-life decisions in perinatal care: a view from health-care providers in Mexico. Salud Publica Mex. 2015;57(6):489-495. https://doi.org/10.21149/spm.v57i6.7637
Gorincour G, Tassy S, Payot A, et al. Decision-making in termination of pregnancy: a French perspective. Gynecol Obstet Fertil. 2011;39(4):198-204. https://doi.org/10.1016/j.gyobfe.2011.02.002
Boyd P, Devigan C, Koshnood B, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndrome. BJOG. 2008;115(6):689-696. https://doi.org/10.1111/j.1471-0528.2008.01700.x
The World’s Abortion Laws [Internet]. 2022. https://reproductiverights.org/maps/worlds-abortion-laws/
Levels M, Sluiter R, Need A. A review of abortion laws in Western-European countries. A cross-national comparison of legal developments between 1960 and 2010. Health Pol. 2014;118(1):95-104. https://doi.org/10.1016/j.healthpol.2014.06.008
Papiernik E, Zeitlin D, Delmas D, et al. Termination of pregnancy among very preterm births and its impact on very preterm mortality: results from ten European population-based cohorts in the MOSAIC study. BJOG. 2008;115(3):361-368. https://doi.org/10.1111/j.1471-0528.2007.01611.x
Garne E, Koshnood B, Loane M, Boyd P, Dolk H, EUROCAT Working Group. Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European register-based study. BJOG. 2010;117(6):660-666. https://doi.org/10.1111/j.1471-0528.2010.02531.x
EUROCAT [Internet]. EUROCAT. 2022. www.eurocat-network.eu
von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495-1499. https://doi.org/10.1016/j.ijsu.2014.07.013
Hoddinott S, Bass M. The dillman total design survey method. Can Fam Physician. 1986;32:2366-2368.
Dombrecht L, Beernaert K, Roets E, et al. A post-mortem population survey on foetal-infantile end-of-life decisions: a research protocol. BMC Pediatr. 2018;18(1):1-9. https://doi.org/10.1186/s12887-018-1218-4
Bosma J, van der Wal G, Hosman-Benjaminse S. Late termination of pregnancy in North Holland. Br J Obstet Gynaecol. 1997;104(4):478-487. https://doi.org/10.1111/j.1471-0528.1997.tb11501.x
Provoost V, Deliens L, Cools F, et al. A classification of end-of-life decisions in neonates and infants. Acta Paediatr. 2004;93(3):301-305. https://doi.org/10.1111/j.1651-2227.2004.tb02950.x
Provoost V, Cools F, Mortier F, et al. Medical end-of-life decisions in neonates and infants in Flanders. Lancet. 2005;364(9467):1315-1320. https://doi.org/10.1016/s0140-6736(05)61028-8
ten Cate K, van de Vathorst S, Onwuteaka-Philipsen B, van der Heide A. End-of-life decisions for children under 1 year of age in The Netherlands: decreased frequency of administration of drugs to deliberately hasten death. J Med Ethics. 2015;41(10):795-798. https://doi.org/10.1136/medethics-2014-102562
Dombrecht L, Beernaert K, Chambaere K, et al. End-of-life decisions in neonates and infants: a nationwide mortality follow-back survey. BMJ Support Palliat Care. 2022. Published Online First. https://doi.org/10.1136/bmjspcare-2021-003357
Bilsen J, Cohen J, Chambaere K, et al. Medical end-of-life practices under the euthanasia law in Belgium. N Engl J Med. 2009;361(11):1119-1121. https://doi.org/10.1056/nejmc0904292
Blondel B, Cuttini M, Hindori-Mohangoo AD, et al. How do late terminations of pregnancy affect comparisons of stillbirth rates in Europe? Analyses of aggregated routine data from the Euro-Peristat Project. BJOG Int J Obstet Gynaecol. 2018;125(2):226-234. https://doi.org/10.1111/1471-0528.14767
Nationale commissie voor de evaluatie van de wet betreffende de zwangerschapsafbreking. Verslag Ten Behoeve Van Het Parlement 1 Januari 2016 - 31 December 2017; 2020.
Hull D, Davies G, Armour C. Survey of the definition of fetal viability and the availability, indications, and decision making processes for post-viability termination of pregnancy for fetal abnormalities and health conditions in Canada. J Genet Couns. 2016;25(3):543-551. https://doi.org/10.1007/s10897-015-9907-8
Kose S, Altunyurt S, Yildirim N, et al. Termination of pregnancy for fetal abnormalities: main arguments and a decision-tree model. Prenat Diagn. 2015;35(11):1128-1136. https://doi.org/10.1002/pd.4662
Sethna C, Davis G, eds. In: Abortion across borders: Transnational travel and access to abortion services. JHU Press; 2019.
Schechtman K, Gray D, Baty J, Rothman M. Decision-making for termination of pregnancies with fetal anomalies: analysis of 53000 pregnancies. Obstet Gynecol. 2002;99(2):216-222. https://doi.org/10.1016/s0029-7844(01)01673-8
Hodgson J, Pitt P, Metcalfe S, et al. Experiences of prenatal diagnosis and decision-making about termination of pregnancy: a qualitative study. Aust N Z J Obstet Gynaecol. 2016;56(6):605-613. https://doi.org/10.1111/ajo.12501
Chervenak F, McCullough LB. Responsibly counselling women about the clinical management of pregnancies complicated by severe fetal anomalies. J Med Ethics. 2012;38(7):397-398. https://doi.org/10.1136/medethics-2012-100491
Chervenak FA, McCullough LB. An ethically justified, clinically comprehensive management strategy for third-trimester pregnancies complicated by fetal anomalies. Obstet Gynecol. 1990;75(3 Pt 1):311-316.
Brown SD, Donelan K, Martins Y, et al. Does professional orientation predict ethical sensitivities? Attitudes of paediatric and obstetric specialists toward fetuses, pregnant women and pregnancy termination. J Med Ethics. 2014;40(2):117-122. https://doi.org/10.1136/medethics-2012-101126
Carnevale A, Lisker R, Villa AR, Casanueva E, Alonso E. Counselling following diagnosis of a fetal abnormality: comparison of different clinical specialists in Mexico. Am J Med Genet. 1997;69(1):23-28. https://doi.org/10.1002/(sici)1096-8628(19970303)69:1<23::aid-ajmg5>3.0.co;2-u
London: Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Gynaecologists RCoOa; 2011.
Kersting A, Wagner B. Complicated grief after perinatal loss. Dialogues Clin Neurosci. 2012;14(2):187-194. https://doi.org/10.31887/dcns.2012.14.2/akersting
Chervenak FA, McCullough LB. Nonaggressive obstetric management: an option for some fetal anomalies during the third trimester. JAMA. 1989;261(23):3439-3440. https://doi.org/10.1001/jama.261.23.3439
Roets E, Dierickx S, Deliens L, et al. Healthcare professionals’ attitudes towards termination of pregnancy at viable stage. Acta Obstet Gynecol Scand. 2021;100(1):74-83. https://doi.org/10.1111/aogs.13967

Auteurs

Ellen Roets (E)

Department of Obstetrics, Women's Clinic, University Hospital Ghent, Ghent, Belgium.

Kim Beernaert (K)

End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium.

Kenneth Chambaere (K)

End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium.

Luc Deliens (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium.

Kim van Berkel (K)

Research Group Reproduction and Genetics, Centre for Medical Genetics, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Clinical Sciences, Brussels, Belgium.

Luc De Catte (L)

Department of Obstetrics and Gynaecology, Division Woman and Child, University Hospitals Leuven, Leuven, Belgium.

Sophie Vanhaesebrouck (S)

Neonatology Department, Ghent University Hospital, Ghent, Belgium.

Kristien Roelens (K)

Department of Obstetrics, Women's Clinic, University Hospital Ghent, Ghent, Belgium.
Department of Human Structure and Repair, Ghent University, Ghent, Belgium.

Laure Dombrecht (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH